Acquisition includes HPN328, an investigational delta-like ligand 3 (DLL3) targeting T-cell engager being evaluated in certain patients with small cell lung cancer and neuroendocrine tumors
The divestment is a part of Fortis' ongoing portfolio rationalization strategy
Investment is additive to KKR’s existing health care growth strategy
Will continue to own a 7.84 per cent stake in Glenmark Life Sciences with the stake reduction
Prior to this, Jim held leadership positions at several companies, including Centrient Pharmaceuticals, Leo Pharmaceuticals, Sandoz, Xellia, and GSK
The Leaders of G20 met in New Delhi and committed to strengthening global health and implementing one health approach
Propranolol LA is a generic equivalent of Inderal LA
Qualicaps is the third largest producer of hard capsules for oral dosage solutions
Subscribe To Our Newsletter & Stay Updated
